A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

L-697,661

DRUG

Zidovudine

Trial Locations (5)

Northwestern Univ Med School, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

Univ of Colorado Health Ctr / Denver Gen Hosp, Denver

San Francisco Gen Hosp, San Francisco

Univ of Washington, Seattle

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00000628 - A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine | Biotech Hunter | Biotech Hunter